10 completed. 10 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 10 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Suicidal Ideation: new trials by email Literature Review of Suicidal Ideation trials Research Report on Suicidal Ideation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NRX-101 for Bipolar Depression With Subacute Suicidal Ideation NRX-101, Lurasidone HCl - Bipolar Depression, Suicidal Ideation and Behavior | Phase 2 / Phase 3 | Completed | NeuroRx, Inc. | 74 | 2022-05-12 | 2024-05-08 |
| The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation Psilocybin - Treatment Resistant Depression, Suicidal Ideation | Phase 2 | Completed | Sheppard Pratt Health System | 20 | 2022-03-28 | 2025-12-24 |
| A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide SLS-002, Placebo, Standard of care - Depressive Disorder, Major, Suicidal | Phase 2 | Completed | Seelos Therapeutics, Inc. | 164 | 2020-12-17 | 2023-09-28 |
| NRX101 Glx Biomarker Validation Study NRX-101, Lurasidone HCl, Placebo - Bipolar Depression, Suicidal Ideation | Phase 2 / Phase 3 | Completed | NeuroRx, Inc. | 8 | 2018-11-01 | 2022-08-09 |
| Electrophysiological Biomarkers of AV-101 Placebo, AV-101 720 mg, AV-101 1440 mg - Healthy | Phase 1 / Phase 2 | Completed | Marijn Lijffijt, PhD | 18 | 2018-09-01 | 2022-02-17 |
| Sequential Therapy for the Treatment of Severe Bipolar Depression. NRX-101 Oral Capsule, Lurasidone Oral Capsule, Ketamine Intravenous Infusion - Bipolar Depression, Suicidal Ideas | Phase 2 | Completed | NeuroRx, Inc. | 22 | 2018-01-15 | 2021-05-25 |
| Aftercare Focus Study (AFS): A Clinical Trial to Reduce Short-Term Suicide Risk After Hospitalization Collaborative Assessment and Management of Suicidality, Treatment as Usual - Suicidal Ideation, Suicide, Attempted | Phase 2 | Completed | University of Washington | 150 | 2015-08-01 | 2021-01-05 |
| miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome ketamine - Major Depressive Disorder | Phase 2 | Completed | University of Alabama at Birmingham | 247 | 2015-04-20 | 2022-08-30 |
| Ketamine for Suicidality in Bipolar Depression Ketamine, Midazolam - Bipolar Disorder, Major Depressive Episode | Phase 1 / Phase 2 | Completed | New York State Psychiatric Institute | 16 | 2013-09-01 | 2020-03-11 |
| Social Connections and Healthy Aging (The Senior Connection) Peer Companionship - Suicidal Ideation, Depression | Phase 2 | Completed | University of Rochester | 368 | 2011-09-01 | 2016-04-22 |
Bipolar Disorder (4) · Depression (4) · Depressive Disorder, Major (3) · Suicide (3) · Suicide, Attempted (3) · Behavior (1) · Behavioral Symptoms (1) · Depressive Disorder (1) · Depressive Disorder, Treatment-Resistant (1) · Mental Disorders (1) · Mood Disorders (1) · Self-Injurious Behavior (1)
Behavior (9) · Behavioral Symptoms (9) · Self-Injurious Behavior (9) · Suicide (7) · Mental Disorders (6) · Mood Disorders (6) · Bipolar and Related Disorders (4) · Depressive Disorder (2)
Ketamine (3) · Lurasidone Hydrochloride (3) · Cycloserine (1) · Midazolam (1) · Psilocybin (1) · Standard of Care (1) · Therapeutics (1)
NeuroRx, Inc. (3) · Marijn Lijffijt, PhD (1) · New York State Psychiatric Institute (1) · Seelos Therapeutics, Inc. (1) · Sheppard Pratt Health System (1) · University of Alabama at Birmingham (1) · University of Rochester (1) · University of Washington (1)
United States (9)
Andrew A Nierenberg, MD (1) · Andrew Nierenberg, MD (1) · Daniel C Javitt, MD (1) · Jonathan C Javitt, MD, MPH (1) · Joshua T Kantrowicz, MD (1) · Katherine A Comtois, PhD, MPH (1) · Marijn Lijffijt, PhD (1) · Martin Brecher, MD (1) · Michael F Grunebaum, M.D. (1) · Richard C Shelton, M.D. (1) · Scott Aaronson, MD (1) · Yogesh Dwivedi, Ph.D. (1)
PMID 32785636, PMID 33318635, PMID 33825765, PMID 34149476, PMID 35735167, PMID 37573534, PMID 39714786, PMID 42138588
R01MH107183 (1)